M. Hussain, M. . Atif, M. Babar, and L. Akhtar, “COMPARISON OF EFFICACY AND SAFETY PROFILE OF EMPAGLIFLOZIN VERSUS DAPAGLIFLOZIN AS ADD ON THERAPY IN TYPE 2 DIABETIC PATIENTS”, J Ayub Med Coll Abbottabad, vol. 33, no. 4, pp. 593–597, Oct. 2021.